These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11837702)

  • 1. Increase in the specific surface area of budesonide during storage postmicronization.
    Joshi V; Dwivedi S; Ward GH
    Pharm Res; 2002 Jan; 19(1):7-12. PubMed ID: 11837702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO; Molokhia AM; Elsayed MM
    Eur J Pharm Biopharm; 2015 Oct; 96():291-303. PubMed ID: 26275831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of mercury porosimetry, assisted by nitrogen adsorption in the investigation of the pore structure of tablets].
    Szepes A; Kovács J; Szabóné Revész P
    Acta Pharm Hung; 2006; 76(3):119-25. PubMed ID: 17094658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.
    Shur J; Pitchayajittipong C; Rogueda P; Price R
    Ther Deliv; 2013 Aug; 4(8):925-37. PubMed ID: 23919472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
    Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pore structure and surface area of mannitol powder, granules and tablets determined with mercury porosimetry and nitrogen adsorption.
    Westermarck S; Juppo AM; Kervinen L; Yliruusi J
    Eur J Pharm Biopharm; 1998 Jul; 46(1):61-8. PubMed ID: 9700023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the mechanism for the decrease in zinc oxide surface area upon high-temperature drying.
    Wurster DE; Oh E; Wang JC
    J Pharm Sci; 1995 Nov; 84(11):1301-7. PubMed ID: 8587047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface modification of lactose inhalation blends by moisture.
    Watling CP; Elliott JA; Scruton C; Cameron RE
    Int J Pharm; 2010 May; 391(1-2):29-37. PubMed ID: 20156536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Particle size and surface area distributions of pharmaceutical powders by microcomputerized mercury porosimetry.
    Carli F; Motta A
    J Pharm Sci; 1984 Feb; 73(2):197-203. PubMed ID: 6707882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of drug particle surface energetics and young's modulus by atomic force microscopy and inverse gas chromatography.
    Davies M; Brindley A; Chen X; Marlow M; Doughty SW; Shrubb I; Roberts CJ
    Pharm Res; 2005 Jul; 22(7):1158-66. PubMed ID: 16028017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particle and pore size distributions of investments.
    Mueller HJ
    J Oral Rehabil; 1986 Jul; 13(4):383-93. PubMed ID: 3020213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of budesonide nanocluster dry powder aerosols: formulation and stability.
    El-Gendy N; Huang S; Selvam P; Soni P; Berkland C
    J Pharm Sci; 2012 Sep; 101(9):3445-55. PubMed ID: 22619045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of process parameters in the ASES process on particle properties of budesonide for pulmonary delivery.
    Steckel H; Pichert L; Müller BW
    Eur J Pharm Biopharm; 2004 May; 57(3):507-12. PubMed ID: 15093600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Textural characterization of native and n-alky-bonded silica monoliths by mercury intrusion/extrusion, inverse size exclusion chromatography and nitrogen adsorption.
    Thommes M; Skudas R; Unger KK; Lubda D
    J Chromatogr A; 2008 May; 1191(1-2):57-66. PubMed ID: 18423477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF-engineered powders for delivery of budesonide from passive DPI devices.
    Lobo JM; Schiavone H; Palakodaty S; York P; Clark A; Tzannis ST
    J Pharm Sci; 2005 Oct; 94(10):2276-88. PubMed ID: 16136557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-leucine microparticles as an excipient to improve the aerosolization performances of dry powders for inhalation.
    Schoubben A; Vivani R; Paolantoni M; Perinelli DR; Gioiello A; Macchiarulo A; Ricci M
    Eur J Pharm Sci; 2019 Mar; 130():54-64. PubMed ID: 30677523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of graphite intercalated compound particle size and exfoliation temperature on porosity and macromolecular diffusion in expanded graphite.
    Goudarzi R; Hashemi Motlagh G
    Heliyon; 2019 Oct; 5(10):e02595. PubMed ID: 31646209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unified method for the total pore volume and pore size distribution of hierarchical zeolites from argon adsorption and mercury intrusion.
    Kenvin J; Jagiello J; Mitchell S; Pérez-Ramírez J
    Langmuir; 2015 Feb; 31(4):1242-7. PubMed ID: 25603366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
    Han X; Ghoroi C; To D; Chen Y; Davé R
    Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.